STATISTICAL ANALYSIS OF 100 BREAST CANCER CASES WITH EVALUATION OF HER2/NEU STATUS IMMUNOHISTOCHEMISTRY CORRELATION WITH GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION ASSAY

被引:0
|
作者
Sivakami [1 ]
Kannan, Indhu [1 ]
Madhusudhanan [1 ]
机构
[1] Meenakshi Mission Hosp & Res Ctr, Dept Pathol, Madurai, Tamil Nadu, India
来源
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS | 2018年 / 7卷 / 49期
关键词
Breast Cancer; Infiltrating Ductal Carcinoma (NOS) HER 2 Gene Immunohistochemistry Fluorescence; in Situ Hybridization;
D O I
10.14260/jemds/2018/1174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Breast cancer has surpassed all other cancers in women becoming the leading cause for mortality. 100 breast cancer cases received in our department of pathology during the period 2016-2017 were evaluated for HER2/neu status and immunohistochemistry correlation with gene amplification by FISH assay. MATERIALS AND METHODS Mastectomy samples received were fixed followed by grossing including all parameters like laterality, size, margin status and adequate lymph node sampling. The tissue sections were stained with H&E for assessing the tumour type, grade, surgical margin clearance study. Lymph node involvement, oestrogen receptor and progesterone receptors Her2/neu was done with immunohistochemistry in the tumour blocks. Subsequently tissue blocks were also subjected to FISH evaluation for Her2/neu. RESULTS The tumour laterality, tumour categorization, staging, and grading were analysed. Comparison of immunohistochemical Her2 results with FISH was done. CONCLUSION Immunohistochemical analysis of Her2/neu with 0 and 1+ Negative. 3+ strong positive had a High concordance with FISH evaluation.
引用
收藏
页码:5298 / 5303
页数:6
相关论文
共 50 条
  • [41] Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer
    Park, Kyeongmee
    Han, Sehwan
    Kim, Jung-Yeon
    Kim, Hyun-Jung
    Kwon, Ji Eun
    Gwak, Geumhee
    JOURNAL OF BREAST CANCER, 2011, 14 (04) : 276 - 282
  • [42] Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients
    Lin Wang
    Xiaobei Wang
    Xiu Nie
    Ling Ma
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29 : 354 - 358
  • [43] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    王琳
    王晓蓓
    聂秀
    马玲
    Current Medical Science, 2009, 29 (03) : 354 - 358
  • [44] HER-2/neu protein expression and gene amplification in breast cancer: immunohistochemistry and chromogenic in situ hybridization study using tissue microarray
    Hazim, Ammar Imad
    Kaur, Gurjeet
    HEALTHMED, 2011, 5 (05): : 1065 - 1071
  • [45] A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer
    Bahreini, Fatemeh
    Soltanian, Ali Reza
    Mehdipour, Parvin
    BREAST CANCER, 2015, 22 (06) : 615 - 625
  • [46] Exploring the heterogeneity of HER2 gene status and expression in non-positive breast cancer patients: insights from immunohistochemistry and fluorescence in situ hybridization
    Zhong, Jingmin
    Gao, Beibei
    Wang, Qingjie
    He, Jun
    Luo, Danjv
    Zhang, Chen
    Fan, Jun
    Nie, Xiu
    DIAGNOSTIC PATHOLOGY, 2025, 20 (01)
  • [47] Assessment of HER-2/neu status in breast cancer using fluorescence in situ hybridization & immunohistochemistry: Experience of a tertiary cancer referral centre in India
    Panjwani, Poonam
    Epari, Sridhar
    Karpate, Arti
    Shirsat, Hemlata
    Rajsekharan, Preetha
    Basak, Ranjan
    Shet, Tanuja
    Chinoy, Roshni
    Chacko, Roy
    Gursale, Sampada
    Baraskar, Nayana
    Gupta, Sudeep
    Hawaldar, Rohini
    Desai, Sangeeta
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2010, 132 (03) : 287 - 294
  • [48] A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer
    Fatemeh Bahreini
    Ali Reza Soltanian
    Parvin Mehdipour
    Breast Cancer, 2015, 22 : 615 - 625
  • [49] 'Genetic heterogeneity' in HER2/neu testing by fluorescence in situ hybridization: a study of 2522 cases
    Chang, Martin C.
    Malowany, Janet I.
    Mazurkiewicz, Julita
    Wood, Martha
    MODERN PATHOLOGY, 2012, 25 (05) : 683 - 688
  • [50] Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization
    Pauletti, G
    Godolphin, W
    Press, MF
    Slamon, DJ
    ONCOGENE, 1996, 13 (01) : 63 - 72